Post-IPO Equity Therapeutics Companies

Modus Therapeutics is a Swedish drug development company focused on normalizing the lives for patients with Sickle Cell Disease.

Psyence develops natural psilocybin products for the treatment of psychological trauma and mental health disorders

Klotho Neurosciences develops disease modifying therapies for age-related cognitive and neurodegenerative disorders and cancer.

Rafael Holdings is a company focused on the development of novel cancer therapies.

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

Stayble Therapeutics is developing a minimally invasive injection-based treatment against chronic low back pain.

Rezolute is a clinical-stage biopharma specializing in the development of drug therapies for patients with metabolic and orphan diseases.

CERo Therapeutics, Inc. is a new cellular immunotherapy company.

A clinical-stage biopharmaceutical company identifying and developing therapeutics for the treatment of fungal and bacterial infections.

RadioPharm Theranostics is a platform of radiopharmaceutical and nuclear medicine products for diagnostic and therapeutic uses.

TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.

RepliCel Life Sciences is a regenerative medicine company using cell therapy products for healing tendinosis, aging, and pattern baldness.

Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action.

CMT focuses on the development and commercialization of regenerative therapies derived from novel processed human platelets.

EXACT Therapeutics is a clinical stage biotech firm developing a technology platform for therapeutic enhancement Acoustic Cluster Therapy.

Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.

Replimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer.

Atlantic Coastal Acquisition Corp. II is a blank check company.

Isla Pharmaceuticals is a biotechnology company that develops tropical disease therapies.

Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.

Aditxt Therapeutics is a biotechnology company that develops a novel nucleic acid-based technology.

LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.

Checkpoint Therapeutics is an immuno-oncology biopharmaceutical company specializing in cancer therapy development.

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

Prokidney provide specialized treatment for chronic kidney disease.